Aksys receives FDA slap on wrist over PHD system
This article was originally published in Clinica
Executive Summary
Aksys, the Lincolnshire, Illinois-based renal care company, came under fire last week when the FDA found out that the company has been marketing its home-use haemodialysis system for a treatment length not approved by the US watchdog.